Replies to post #1734 on Virios Therapeutics Inc (VIRI)

[07up]

Here is one of the potential catalysts:

Top line results from the exploratory Long-COVID study, featuring the combination of valacyclovir and celecoxib to treat Long-COVID sequelae, are expected in June 2023